drugset / Trial / NCT01770145
Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT)
NaSingle-groupOpen-labelTreatment
Summary
This study is designed to assess the effect of APOKYN treatment in rapid and reliable improvement of motor symptoms in Parkinson's disease (PD) subjects suffering from delayed or unreliable onset of levodopa (L-dopa) action.
Timeline
- Start
- 2012-12
- Primary completion
- 2014-04
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Apomorphine | Unknown | — | Subcutaneous |
| Background | Levodopa | Small molecule | — | — |
| Background | Trimethobenzamide | Small molecule | 300 mg | Oral |